Merrimack Pharmaceuticals

Investors
- Press Releases
- Events & Presentations
- Corporate Governance
- Overview
- Board of Directors
- Committee Composition
- Board Diversity Matrix
- SEC Filings
- Stock Information
- Stock Quote & Chart
- Historic Stock Lookup
- Investment Calculator
- Investor FAQs
- Contact IR
Contact

Development of TNF superfamily agonists: 4-1BB ligand fusion shows anti-tumor activity in vivo

Press Release

Development of TNF superfamily agonists: 4-1BB ligand fusion shows anti-tumor activity in vivo

Back to top

One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

Privacy Policy
Terms of Use
Contact

© 2023 Merrimack.